Schlusskurs
Andere Börsenplätze
|
||
- | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Hao Leng Lin
CEO | Chief Executive Officer | - | 09.04.10 |
Yao Lu Chien
DFI | Director of Finance/CFO | - | 01.06.08 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Wan Lai Cheng
CHM | Chairman | - | 09.04.10 |
Jung Chin Lin
BRD | Director/Board Member | 70 | 09.04.10 |
Chun Hung Chen
BRD | Director/Board Member | 69 | 09.04.10 |
Hao Leng Lin
CEO | Chief Executive Officer | - | 09.04.10 |
Hui Chung Hsiao
BRD | Director/Board Member | - | 09.04.10 |
Kuo Lung Yan
BRD | Director/Board Member | - | 27.06.16 |
Sheng Hung Huang
BRD | Director/Board Member | - | 27.06.16 |
Wen Hung Huang
BRD | Director/Board Member | - | 27.06.16 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 24 180 000 | 12 419 826 ( 51,36 %) | 0 | 51,36 % |
Unternehmenskontakt
Glory Biotech Co., Ltd.
Min-Hsiung Industrial Park No. 10 Hsin-Sheng Street
62158, Chiayi
+
http://www.glorybiotech.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+17.55% | 43.26 Mrd. | |
+17.07% | 21.6 Mrd. | |
+21.10% | 15.93 Mrd. | |
+24.48% | 15.1 Mrd. | |
+55.33% | 12.95 Mrd. | |
-0.05% | 6.79 Mrd. | |
-16.18% | 6.29 Mrd. | |
+19.77% | 6.04 Mrd. | |
-8.87% | 5.73 Mrd. |
- Börse
- Aktien
- 4187 Aktie
- Unternehmen Glory Biotech Co Ltd